120 results in Exploration of Neuroprotective Therapy
Most Viewed
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Review
Balancing cholesterol in the brain: from synthesis to disposal
Lydia Qian ... Andrew J. Brown
Published: January 05, 2022 Explor Neuroprot Ther. 2022;2:1–27
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
21429 560 16
Open Access Review
Resolving a paradox: antidepressants, neuroinflammation, and neurodegeneration
Ravi Philip Rajkumar
Published: February 23, 2024 Explor Neuroprot Ther. 2024;4:11–37
20745 141 5
Open Access Review
Biomarkers in small fiber neuropathy
Amanda C. Y. Chan ... Joy Vijayan
Published: December 30, 2022 Explor Neuroprot Ther. 2022;2:264–283
This article belongs to the special issue The Future of Biomarkers in CNS Diseases
20494 185 2
Open Access Review
Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation
Khaled Radad ... Wolf-Dieter Rausch
Published: February 27, 2023 Explor Neuroprot Ther. 2023;3:24–46
20072 381 31
Open Access Case Report
Hyperbaric oxygen therapy—a new hope for Alzheimer’s patients: a case report and literature review
Elizabeta B. Mukaetova-Ladinska ... Qadeer Arshad
Published: December 22, 2023 Explor Neuroprot Ther. 2023;3:457–469
17998 130 1
Open Access Review
Biomarkers in neurodegenerative diseases: a broad overview
Sathish Selvam, Velpandi Ayyavoo
Published: April 16, 2024 Explor Neuroprot Ther. 2024;4:119–147
This article belongs to the special issue The Future of Biomarkers in CNS Diseases
15604 359 15
Open Access Review
The potential positive effects of coenzyme Q10 on the regeneration of peripheral nerve injury
Ahmed Mead ... Süleyman Kaplan
Published: June 21, 2024 Explor Neuroprot Ther. 2024;4:288–299
15180 122 1
Open Access Review
Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease
Kamran Tariq, Bryan W. Luikart
Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:86–110
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
14092 369 38
Open Access Systematic Review
Various facets of excitotoxicity
Talita Glaser ... Henning Ulrich
Published: February 23, 2022 Explor Neuroprot Ther. 2022;2:36–64
13947 232 9
Open Access Review
Neuroprotective agents in acute ischemic stroke
Grace YY Chia ... Benjamin YQ Tan
Published: February 28, 2023 Explor Neuroprot Ther. 2023;3:47–70
This article belongs to the special issue The Future of Biomarkers in CNS Diseases
13957 270 1
Open Access Review
Advances in neuroprotective therapy for acute ischemic stroke
Yang Yang ... Yi Li
Published: February 27, 2024 Explor Neuroprot Ther. 2024;4:55–71
This article belongs to the special issue Therapeutic Targets for Neuroprotection in Ischemic Stroke
12603 250 2
Open Access Review
Targeting α-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson’s disease
Gabriela Henriquez, Mahesh Narayan
Published: August 25, 2023 Explor Neuroprot Ther. 2023;3:207–234
11513 203 15
Open Access Perspective
Can meditation-based approaches improve the cleansing power of the glymphatic system?
Peter Wostyn, Piet Goddaer
Published: June 20, 2022 Explor Neuroprot Ther. 2022;2:110–117
11491 179 4
Open Access Review
Exploration of transcutaneous vagus nerve stimulation as a treatment option for adjuvant cancer and heart failure therapy
Niklas Frank ... Carola Y. Förster
Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:363–397
This article belongs to the special issue Intervention of Neuroimmune Responses
11464 95 7
Open Access Systematic Review
Effect of gardening physical activity on neuroplasticity and cognitive function
Antonio G. Lentoor
Published: June 05, 2024 Explor Neuroprot Ther. 2024;4:251–272
11321 214 7
Open Access Review
An overview of the role of monoamine oxidase-B in Parkinson’s disease: implications for neurodegeneration and therapy
Praveen Kumar Chandra Sekar ... Ramakrishnan Veerabathiran
Published: July 14, 2024 Explor Neuroprot Ther. 2024;4:308–318
10918 131 2
Open Access Mini Review
Impaired glymphatic clearance is an important cause of Alzheimer’s disease
Iyawnna Hazzard ... Forshing Lui
Published: October 24, 2024 Explor Neuroprot Ther. 2024;4:401–410
10447 73 1
Open Access Review
From the ocean to the brain: harnessing the power of marine algae for neuroprotection and therapeutic advances
Leonel Pereira, Ana Valado
Published: November 17, 2023 Explor Neuroprot Ther. 2023;3:409–428
This article belongs to the special issue Natural Products in Neurotherapeutic Applications
10168 175 4
Open Access Review
Neurological complications during HIV infection
Jose M. Martinez-Navio
Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:19–32
10125 303 1